Parenteral Commercial Services Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 30 Year, 11 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 547.55 Cr
as on 18-12-2024
- Satisfied Charges ₹ 16.95 Cr
as on 18-12-2024
- Revenue %
(FY 2021)
- Profit 90.50%
(FY 2021)
- Ebitda 87.20%
(FY 2021)
- Net Worth -0.18%
(FY 2021)
- Total Assets 1.53%
(FY 2021)
About Parenteral Commercial Services
The Company is engaged in the Transport And Logistics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹547.55 Cr. The company has closed loans amounting to ₹16.95 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ayush Gupta and Amit Gupta serve as directors at the Company.
- CIN/LLPIN
U63090MP1994PTC008037
- Company No.
008037
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 1994
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Parenteral Commercial Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayush Gupta  | Director | 01-Sep-2014 | Current |
| Amit Gupta | Director | 12-Feb-2019 | Current |
Financial Performance of Parenteral Commercial Services.
Parenteral Commercial Services Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 90.5% increase in profit. The company's net worth dipped by a decrease of 0.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parenteral Commercial Services?
In 2021, Parenteral Commercial Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Apr 2015 | ₹95.63 Cr | Open |
State Bank Of India Creation Date: 22 Jan 2015 | ₹451.92 Cr | Open |
Others Creation Date: 06 Dec 2017 | ₹2.95 Cr | Satisfied |
How Many Employees Work at Parenteral Commercial Services?
Unlock and access historical data on people associated with Parenteral Commercial Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parenteral Commercial Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parenteral Commercial Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
